1. Home
  2. CABR vs CODX Comparison

CABR vs CODX Comparison

Compare CABR & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CABR

Caring Brands Inc.

N/A

Current Price

$0.90

Market Cap

19.2M

ML Signal

N/A

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.18

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABR
CODX
Founded
2020
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
15.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CABR
CODX
Price
$0.90
$0.18
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.25
AVG Volume (30 Days)
181.2K
1.6M
Earning Date
03-20-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,493.00
$507,892.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.22
52 Week High
$6.00
$1.55

Technical Indicators

Market Signals
Indicator
CABR
CODX
Relative Strength Index (RSI) N/A 30.03
Support Level N/A $0.22
Resistance Level N/A $0.30
Average True Range (ATR) 0.00 0.03
MACD 0.00 -0.01
Stochastic Oscillator 0.00 2.05

Price Performance

Historical Comparison
CABR
CODX

About CABR Caring Brands Inc.

Caring Brands Inc is a consumer wellness company specializing in over-the-counter (OTC) and cosmetic products.support health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. It product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Company's majority of revenue is generated through the sales of OTC and consumer products and licensing royalties.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: